SecBot SecBot
SECBOTREPLAY Home › Report › BMRN

BMRN · BlackRock 13G/A 10.0% stake

BIOMARIN PHARMACEUTICAL INC · SC 13G/A filed Nov 4, 2026 at 16:04 ET

At the news

NEUTRALIMPACT 3/10

SC 13G/A filed Nov 4, 2026 at 16:04 ET

BlackRock filed an amended Schedule 13G disclosing beneficial ownership of 19,373,309 shares of BioMarin common stock, representing 10.0% of shares outstanding as of October 31, 2026. This is an increase from the prior filing (Vanguard's April 2026 filing showed 18,549,911 shares at 10.0%), indicating BlackRock added approximately 823,398 shares. The filing is a routine passive stake update by a large index/asset manager, filed two days after BioMarin reported Q3 revenue up 32% YoY but lowered full-year guidance.

  • BlackRock reported beneficial ownership of 19,373,309 shares of BioMarin common stock as of October 31, 2026
  • Stake represents 10.0% of outstanding shares
  • BlackRock Fund Advisors is the entity that beneficially owns 5% or more of the class
  • This is an amendment to a prior Schedule 13G filing

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access